A novel AI-powered method can detect hidden brain lesions on standard MRI scans of multiple sclerosis patients, catching damage strongly linked to disability and cognitive decline that would otherwise go unnoticed. The approach, developed by researchers at a collaboration described in Genetic Engineering News, integrates artificial intelligence with multiple image processing techniques to identify cortical lesions—a hallmark of disease progression that conventional imaging routinely misses.
Cortical lesions are small, subtle abnormalities in the brain's outer layer that correlate tightly with physical and cognitive impairment in MS. Standard clinical MRI protocols have limited sensitivity to these lesions, often failing to visualize them despite their clinical significance. The new tool leverages AI to enhance existing scan data, reliably measuring these lesions without requiring specialized, expensive imaging hardware.
The work addresses a long-standing diagnostic gap. By applying the method to routine MRI scans, clinicians could potentially gauge disease severity and progression with greater accuracy, using data already collected during standard care. This could enable earlier, more targeted interventions for patients whose scans appear unremarkable but who experience worsening symptoms.
No specific timeline for clinical deployment was provided in the report. The technology remains at the research stage, with validation in larger, diverse patient populations still needed before it could enter routine practice. Regulatory pathway details and commercialization plans were not disclosed.
If confirmed, the approach could reshape how MS is monitored, offering a low-cost way to extract hidden prognostic information from ordinary scans. However, experts caution that the method requires rigorous prospective testing to ensure its findings translate into meaningful improvements in patient outcomes.